Review
Accepted on 29 Jul 2025
Epigenetic Regulation of Bladder Cancer in the Context of Aging
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1617452
- 389 views
Type at least 3 characters
613 articles
Original Research
Accepted on 28 Jul 2025
The prevalence of Ggenetic variants of the Mas-related G-proteincoupled receptor X2 in patients experiencing does not explain perioperative hypersensitivity reactions to neuromuscular blocking agents
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1655722
- 222 views
Review
Accepted on 28 Jul 2025
Role of pharmacogenomics for prevention of hypersensitivity reactions induced by Aromatic Antiseizure Medications
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1640401
- 109 views
Correction
Accepted on 25 Jul 2025
Corrigendum: Overexpression of Nrf2 in bone marrow mesenchymal stem cells promotes B-cell acute lymphoblastic leukemia cells invasion and extramedullary organ infiltration through stimulation of the SDF-1/CXCR4 axis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1660169
- 146 views
Clinical Trial
Accepted on 24 Jul 2025
Clinicians' experience on the effectiveness of pharmacotherapy in patients with first-episode depression: A randomized controlled trial based on pharmacogenomics
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626654
Original Research
Published on 21 Jul 2025
Clinical significance and gene prediction of a novel classification system based on tacrolimus concentration-to-dose ratio in the early post-liver transplant period
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1614753
- 536 views
Original Research
Accepted on 20 Jul 2025
Analysis of six CYP450 genetic variants regarding the response to Cannabidiol combined with anticonvulsant medication in Mexican patients with drug-resistant epilepsy
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1626054
- 204 views
Mini Review
Published on 17 Jul 2025
Statins and their impact on epigenetic regulation: insights into disease
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1621163
- 868 views
Review
Published on 16 Jul 2025
Epigenetic modifications of gut microbiota and their potential role in atherosclerosis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1638240
- 734 views
Systematic Review
Published on 16 Jul 2025
Polymorphisms in CYP3A5, CYP3A4, and ABCB1 genes: implications for calcineurin inhibitors therapy in hematopoietic cell transplantation recipients—a systematic review
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1569353
- 765 views
Systematic Review
Published on 16 Jul 2025
Clinical and cost-effectiveness of pharmacogenomic testing for anthracycline-induced cardiotoxicity in childhood cancer: a systematic review and meta-analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1568320
- 1,259 views
Editorial
Published on 15 Jul 2025
Editorial: Editor’s feature: negative findings in pharmacogenetics and pharmacogenomics volume II
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1658876
- 584 views
Original Research
Accepted on 07 Jul 2025
Population-Specific Genetic Differences of Acute Coronary Syndrome in Han and Uyghur Chinese
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1588658
- 207 views
Editorial
Published on 07 Jul 2025
Editorial: Post-translational modifications in human cancer: pharmacological insights and therapeutic opportunities
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1654659
- 797 views
Original Research
Published on 04 Jul 2025
Exploring biomarkers for noise-induced hearing loss through mitochondrial DNA methylation analysis
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1561791
- 1,174 views
Editorial
Published on 01 Jul 2025
Editorial: Pharmacogenomics for improving drug safety and efficacy in cancer
in Pharmacogenetics and Pharmacogenomics
Frontiers in Pharmacology
doi 10.3389/fphar.2025.1649258
- 1,032 views